Tetraphase Pharmaceuticals is one of the companies that continue to develop novelty products that would address this condition. The company is a clinical stage biopharmaceutical company that aims to provide the world with the medication to combat these life-threatening and serious diseases. The company’s lead product is branded as eravacycline and is administered intravenously or orally. This product is created to treat multi-drug resistant infections, including multi-drug resistant Gram-negative bacteria.
Tetraphase continues to study their product to possibly use it to treat other forms of infection and diseases. Headquartered in Watertown, Massachusetts, the company has been around since 2006. It remains steadfast in its commitment to provide the world the chemistry, technology to address the global crisis brought about by antibiotic resistance.